Grace Therapeutics Inc Share Price Today: Live Updates & Key Insights
Grace Therapeutics Inc share price today is $2.32, up -0.85%. The stock opened at $2.31 against the previous close of $2.35, with an intraday high of $2.33 and low of $2.3.
Grace Therapeutics Inc Share Price Chart
Grace Therapeutics Inc
Grace Therapeutics Inc Share Price Performance
Grace Therapeutics Inc Institutional Holdings
Grace Therapeutics Inc Market Status
Grace Therapeutics Inc Fundamentals
Market Cap 38.24 M
PB Ratio 0.6036
PE Ratio 0.0
Enterprise Value 21.59 M
Total Assets 66.65 M
Volume 127089
Grace Therapeutics Inc Company Financials
About Grace Therapeutics Inc & investment objective
Company Information Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an injectable formulation developed to treat aneurysmal subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to enhance neurological symptoms of Ataxia-Telangiectasia (A-T); and GTX-101, a topical bio adhesive film-forming bupivacaine spray for the treatment of pain associated with postherpetic neuralgia (PHN). The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. Grace Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.
Organisation Biotechnology
Employees 5
Industry Biotechnology
CEO Mr. Prashant Kohli
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Grace Therapeutics Inc FAQs
What is the share price of Grace Therapeutics Inc today?
The current share price of Grace Therapeutics Inc is $2.32.
Can I buy Grace Therapeutics Inc shares in India?
Yes, Indian investors can buy Grace Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Grace Therapeutics Inc shares in India?
You can easily invest in Grace Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Grace Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Grace Therapeutics Inc.
Can I buy fractional shares of Grace Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Grace Therapeutics Inc?
Grace Therapeutics Inc has a market cap of $38.24 M.
In which sector does Grace Therapeutics Inc belong?
Grace Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Grace Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Grace Therapeutics Inc?
The PE ratio of Grace Therapeutics Inc is N/A and the PB ratio is 0.60.